Patents by Inventor John K Sullivan

John K Sullivan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Conjugated toxin peptide therapeutic agents
    Publication number: 20090291885
    Abstract: Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.
    Type: Application
    Filed: October 25, 2007
    Publication date: November 26, 2009
    Inventors: John K. Sullivan, Joseph G. McGivern, Leslie P. Miranda, Hung Q. Nguyen, Kenneth W. Walker, Shaw-Fen Sylvia Hu, Colin V. Gegg, JR., Taruna Arora Khare, Beverly S. Adler, Francis H. Martin
  • OSK1 peptide analogs and pharmaceutical compositions
    Publication number: 20090281028
    Abstract: Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.
    Type: Application
    Filed: October 25, 2007
    Publication date: November 12, 2009
    Inventors: John K. Sullivan, Joseph G. McGivern, Leslie P. Miranda
  • B7-Like Molecules and Uses Thereof
    Publication number: 20090004237
    Abstract: The present invention provides B7-Like (B7-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing B7-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with B7-L polypeptides.
    Type: Application
    Filed: June 27, 2008
    Publication date: January 1, 2009
    Applicant: AMGEN, INC.
    Inventors: Gary M. Fox, John K. Sullivan, Paige Holst, Steven Kiyoshi Yoshinaga
  • Nucleic acids encoding B7-Like molecules and uses thereof
    Patent number: 7414122
    Abstract: The present invention provides B7-Like (B7-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing B7-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with B7-L polypeptides.
    Type: Grant
    Filed: November 29, 2004
    Date of Patent: August 19, 2008
    Assignee: Amgen Inc.
    Inventors: Gary M. Fox, John K Sullivan, Paige Holst, Steven Kiyoshi Yoshinaga
  • Selective binding agents of osteoprotegerin binding protein
    Publication number: 20030103978
    Abstract: Selective binding agents of osteoprotegerin binding protein (OPGbp) are provided by the invention. More particularly, the invention provides for antibodies and antigen binding domains which selectively bind to OPGbp and may be used to prevent or treat conditions relating to loss of bone mass. Nucleic acid molecules encoding said antibodies and antigen binding domains, and expression vectors and host cells for the production of same are also provided.
    Type: Application
    Filed: February 22, 2001
    Publication date: June 5, 2003
    Applicant: Amgen Inc.
    Inventors: Rajendra V. Deshpande, Anna Hitz, William James Boyle, John K. Sullivan
  • B7-like molecules and uses thereof
    Publication number: 20020165347
    Abstract: The present invention provides B7-Like (B7-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing B7-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with B7-L polypeptides.
    Type: Application
    Filed: June 29, 2001
    Publication date: November 7, 2002
    Applicant: Amgen, Inc.
    Inventors: Gary M. Fox, John K. Sullivan, Mei Fang
  • B7-Like molecules and uses thereof
    Publication number: 20020107363
    Abstract: The present invention provides B7-Like (B7-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing B7-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with B7-L polypeptides.
    Type: Application
    Filed: September 19, 2001
    Publication date: August 8, 2002
    Applicant: Amgen, Inc.
    Inventors: Gary M. Fox, John K. Sullivan, Paige Holst, Steven Kiyoshi Yoshinaga